318 related articles for article (PubMed ID: 11852996)
1. Order and disorder: the role of extracellular matrix in epithelial cancer.
Radisky D; Muschler J; Bissell MJ
Cancer Invest; 2002; 20(1):139-53. PubMed ID: 11852996
[No Abstract] [Full Text] [Related]
2. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS
Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix and tenascin-C in pathogenesis of breast cancer.
Jones PL
Lancet; 2001 Jun; 357(9273):1992-4. PubMed ID: 11438127
[No Abstract] [Full Text] [Related]
4. Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via β1 integrin and PTEN signals.
Shen Y; Shen R; Ge L; Zhu Q; Li F
Int J Gynecol Cancer; 2012 Oct; 22(8):1316-24. PubMed ID: 23013730
[TBL] [Abstract][Full Text] [Related]
5. A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours.
Fu R; Han CF; Ni T; Di L; Liu LJ; Lv WC; Bi YR; Jiang N; He Y; Li HM; Wang S; Xie H; Chen BA; Wang XS; Weiss SJ; Lu T; Guo QL; Wu ZQ
Nat Commun; 2019 Jul; 10(1):3210. PubMed ID: 31324807
[TBL] [Abstract][Full Text] [Related]
6. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.
Chen CH; Shyu MK; Wang SW; Chou CH; Huang MJ; Lin TC; Chen ST; Lin HH; Huang MC
Gynecol Oncol; 2016 Jan; 140(1):131-7. PubMed ID: 26616226
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
8. Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes.
van der Steen SC; Raavé R; Langerak S; van Houdt L; van Duijnhoven SM; van Lith SA; Massuger LF; Daamen WF; Leenders WP; van Kuppevelt TH
Eur J Pharm Biopharm; 2017 Apr; 113():229-239. PubMed ID: 28034806
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of putative metastatic precursor cells in cancer patients.
Alix-Panabières C; Vendrell JP; Pellé O; Rebillard X; Riethdorf S; Müller V; Fabbro M; Pantel K
Clin Chem; 2007 Mar; 53(3):537-9. PubMed ID: 17327507
[No Abstract] [Full Text] [Related]
10. Colonization of epithelial pilar neoplasms by melanocytes.
Aly Z; Pozo L; Diaz-Cano SJ
Histopathology; 2006 Jan; 48(2):213-7. PubMed ID: 16405678
[No Abstract] [Full Text] [Related]
11. The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer.
Sonoda K; Miyamoto S; Kobayashi H; Ogawa S; Okugawa K; Taniguchi S; Wake N
Int J Gynecol Cancer; 2009 Jul; 19(5):838-43. PubMed ID: 19574770
[TBL] [Abstract][Full Text] [Related]
12. Expression of epithelial cancer-related antigens in hematologic malignancies applicable for peptide-based immunotherapy.
Takedatsu H; Okamura T; Yoshimoto K; Harada M; Koga M; Shichijo S; Sata M; Itoh K
J Immunother; 2004; 27(4):289-97. PubMed ID: 15235390
[TBL] [Abstract][Full Text] [Related]
13. Intracellular versican expression in mesenchymal spindle cell tumors contrasts with extracellular expression in epithelial and other tumors--a tissue microarray-based study.
Bhardwaj A; Frankel WL; Pellegata NS; Wen P; Prasad ML
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):263-6. PubMed ID: 18301243
[TBL] [Abstract][Full Text] [Related]
14. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.
Lee M
J Gynecol Oncol; 2014 Oct; 25(4):352-4. PubMed ID: 25310035
[No Abstract] [Full Text] [Related]
16. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
17. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
18. Stromal fibroblasts in cancer initiation and progression.
Bhowmick NA; Neilson EG; Moses HL
Nature; 2004 Nov; 432(7015):332-7. PubMed ID: 15549095
[TBL] [Abstract][Full Text] [Related]
19. MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study.
Sang M; Wu X; Fan X; Lian Y; Sang M
Gynecol Endocrinol; 2017 Jun; 33(6):480-484. PubMed ID: 28277121
[TBL] [Abstract][Full Text] [Related]
20. Pten in stromal fibroblasts suppresses mammary epithelial tumours.
Trimboli AJ; Cantemir-Stone CZ; Li F; Wallace JA; Merchant A; Creasap N; Thompson JC; Caserta E; Wang H; Chong JL; Naidu S; Wei G; Sharma SM; Stephens JA; Fernandez SA; Gurcan MN; Weinstein MB; Barsky SH; Yee L; Rosol TJ; Stromberg PC; Robinson ML; Pepin F; Hallett M; Park M; Ostrowski MC; Leone G
Nature; 2009 Oct; 461(7267):1084-91. PubMed ID: 19847259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
